PMID- 15855637 OWN - NLM STAT- MEDLINE DCOM- 20050621 LR - 20230513 IS - 0002-9440 (Print) IS - 1525-2191 (Electronic) IS - 0002-9440 (Linking) VI - 166 IP - 5 DP - 2005 May TI - Absence of proteinase-activated receptor-1 signaling affords protection from bleomycin-induced lung inflammation and fibrosis. PG - 1353-65 AB - Activation of the coagulation cascade is commonly observed in the lungs of patients with both acute and chronic inflammatory and fibrotic lung disorders, as well as in animal models of these disorders. The aim of this study was to examine the contribution of the major thrombin receptor, proteinase-activated receptor-1 (PAR-1), during the acute inflammatory and chronic fibrotic phases of lung injury induced by intratracheal instillation of bleomycin in mice. Inflammatory cell recruitment and increases in bronchoalveolar lavage fluid (BALF) protein were attenuated by 56 +/- 10% (P < 0.05) and 53 +/- 12% (P < 0.05), respectively, in PAR-1-deficient (PAR-1-/-) mice compared with wild-type (WT) mice. PAR-1-/- mice were also protected from bleomycin-induced pulmonary fibrosis with total lung collagen accumulation reduced by 59 +/- 5% (P < 0.05). The protection afforded by PAR-1 deficiency was accompanied by significant reductions in pulmonary levels of the potent PAR-1-inducible proinflammatory and profibrotic mediators, monocyte chemoattractant protein-1 (MCP-1), transforming growth factor-beta-1 (TGF-beta1), and connective tissue growth factor/fibroblast-inducible secreted protein-12 (CTGF/FISP12). In addition, PAR-1 was highly expressed in inflammatory and fibroproliferative lesions in lung sections obtained from patients with fibrotic lung disease. These data show for the first time that PAR-1 signaling plays a key role in experimentally induced lung injury, and they further identify PAR-1 as one of the critical receptors involved in orchestrating the interplay between coagulation, inflammation, and remodeling in response to tissue injury. FAU - Howell, David C J AU - Howell DC AD - Centre for Respiratory Research, University College London, The Rayne Institute, 5 University Street, London WC1E 6JJ, United Kingdom. FAU - Johns, Robin H AU - Johns RH FAU - Lasky, Joseph A AU - Lasky JA FAU - Shan, Bin AU - Shan B FAU - Scotton, Chris J AU - Scotton CJ FAU - Laurent, Geoffrey J AU - Laurent GJ FAU - Chambers, Rachel C AU - Chambers RC LA - eng GR - WT_/Wellcome Trust/United Kingdom PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Am J Pathol JT - The American journal of pathology JID - 0370502 RN - 0 (CCN2 protein, human) RN - 0 (CCN2 protein, mouse) RN - 0 (Immediate-Early Proteins) RN - 0 (Intercellular Signaling Peptides and Proteins) RN - 0 (Receptor, PAR-1) RN - 0 (TGFB1 protein, human) RN - 0 (Tgfb1 protein, mouse) RN - 0 (Transforming Growth Factor beta) RN - 0 (Transforming Growth Factor beta1) RN - 11056-06-7 (Bleomycin) RN - 139568-91-5 (Connective Tissue Growth Factor) SB - IM MH - Animals MH - Biopsy MH - *Bleomycin MH - Bronchoalveolar Lavage Fluid/cytology MH - Capillary Permeability MH - Cell Count MH - Connective Tissue Growth Factor MH - Cytoprotection MH - Humans MH - Immediate-Early Proteins/metabolism MH - Immunohistochemistry MH - Intercellular Signaling Peptides and Proteins/metabolism MH - Lung/metabolism/pathology MH - Mice MH - Mice, Inbred C57BL MH - Mice, Knockout MH - Pneumonia/*chemically induced/metabolism/pathology/physiopathology MH - Pulmonary Fibrosis/*chemically induced/metabolism/pathology/physiopathology MH - Receptor, PAR-1/deficiency/*metabolism MH - *Signal Transduction MH - Transforming Growth Factor beta/metabolism MH - Transforming Growth Factor beta1 PMC - PMC1606391 EDAT- 2005/04/28 09:00 MHDA- 2005/06/23 09:00 PMCR- 2005/11/01 CRDT- 2005/04/28 09:00 PHST- 2005/04/28 09:00 [pubmed] PHST- 2005/06/23 09:00 [medline] PHST- 2005/04/28 09:00 [entrez] PHST- 2005/11/01 00:00 [pmc-release] AID - S0002-9440(10)62354-1 [pii] AID - 10.1016/S0002-9440(10)62354-1 [doi] PST - ppublish SO - Am J Pathol. 2005 May;166(5):1353-65. doi: 10.1016/S0002-9440(10)62354-1.